A new Belgian algorithm may help clinicians choose adjuvant therapy more precisely in early endometrial cancer, moving beyond ...

Hormone receptor and HER2 assessment remains the cornerstone for breast cancer subtyping and initial systemic therapy ...

This surgery, which is often considered “out of network” by insurance, involves removing all signs of visible disease ...

A Frederick County woman who has faced fertility issues, two cancer diagnoses and a hysterectomy is sharing her story to ...

Merck & Co.’s almighty Keytruda has become the first PD-1 inhibitor to show a benefit as a single agent for the front-line treatment of a subtype of endometrial cancer. Keytruda significantly improved ...

A new treatment for endometrial cancer demonstrated strong potential in a Phase 3 clinical trial. Drugmaker Merck announced Monday that the investigational drug sacituzumab tirumotecan (sac-TMT) met ...

Over the last 18 months, Merck and Kelun-Biotech have notched four approvals in China for their TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT). And now, after meeting ...

May 18 (Reuters) - Merck (MRK.N), opens new tab said on Monday its experimental drug helped certain patients with uterine cancer live longer and kept their disease from worsening in ‌a late-stage ...

Overall, 91% of patients agreed that they would like to know about treatment options besides chemotherapy. Patients with endometrial cancer want an individualized, collaborative approach to their ...

Endometrial cancer is the most common gynecologic cancer in the United States and is one of the few cancers in which survival rates have steadily declined over the last few decades. The most ...

In January, the American Cancer Society reported that for the first time women younger than 50 had a higher cancer incidence rate than men. Based on 2023 data, cancer incidence rates among women under ...

Uterine cancer is the fourth most common cancer and the sixth most common cause of death among women in the United States. The preferred treatment is a hysterectomy, and young women who want to have ...